tirzepatide court ruling on A federal court in Delaware has dismissed Eli Lilly's lawsuit against Strive court ruling on tirzepatide Lilly

Monitoring and Prevention To minimize the risk of gallstones while on semaglutide: Regular Check-Ups: Schedule regular healthcare visits to monitor for side effects, including blood tests and ultrasounds

Semaglutide is a GLP-1 receptor agonist that mimics a hormone produced in the gut after eating

After at least 4 weeks at 2.4 mg, your prescriber may increase the dose to 7.2 mg if you have a BMI of 30 or higher and would benefit from additional weight loss

Another study looked more closely at what happens when people stay on tirzepatide versus stop after the initial weight loss

British Journal of Dermatology 2014;171(6):1402-06 [PubMed: 24773124] 41